China NT Pharma Group Company Limited provided earnings guidance for the full year of 2020. For the period, the Group is expected to record a net loss of approximately RMB 85.0 million for the period under review, as compared to a net profit of RMB 3.7 million recorded for the corresponding period in 2019.